Press "esc" to clear
Go to Advanced Search

Showing results

110 of 814
Yostenlab.jpg

Article ID: 695099

SLU Scientist Aims to Turn on Hypoglycemia’s Missed Signal

Saint Louis University Medical Center

Saint Louis University researcher Gina Yosten, Ph.D is pursuing solutions for people with diabetes who are at risk of life-threatening drops in blood sugar.

Released:
24-May-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
baccarini_illu.jpg
  • Embargo expired:
    24-May-2018 11:00 AM EDT

Article ID: 695064

A System of Check and Balances in the Blood

University of Vienna

Hematopoietic Stem Cells (HSCs) give rise to blood and immune cells of the body, and are therefore essential for our survival. They are in a dormant state, but whenever new blood needs to be formed, such as after blood loss or chemotherapy, they are rapidly activated to compensate for the loss. After completing their mission, they need to go back to their dormant state. The group of Manuela Baccarini at the Max F. Perutz Laboratories, a joint venture of the University of Vienna and the Medical University of Vienna, has now shown how intracellular signalling can safeguard this delicate balance between activation and dormancy. Their results are published in the prominent journal Cell Stem Cell.

Released:
24-May-2018 4:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
GettyImages-624965484.jpg

Article ID: 695066

Study Finds Sepsis Patients Treated and Released From Emergency Departments Do Well with Outpatient Follow-Up

Intermountain Medical Center

National guidelines assume that all patients who’re diagnosed with clinical sepsis in an emergency department will be admitted to the hospital for additional care, but new research has found that many more patients are being treated and released from the ED for outpatient follow-up than previously recognized.

Released:
24-May-2018 5:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695042

U-M Rogel Cancer Center First in Michigan to Offer All FDA Approved Car T-Cell Therapies

Michigan Medicine - University of Michigan

With the recently announced FDA approval of Kymriah to treat adults with lymphoma, the University of Michigan Rogel Cancer Center is the first center in Michigan to offer all currently available CAR T-cell therapies.

Released:
23-May-2018 3:20 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 694951

UT Southwestern Surgeons Among World’s First to Repair Aortic Arch Aneurysm with Leading-Edge Technique

UT Southwestern Medical Center

James Isbon was the second patient in the United States and the seventh in the world to have an aneurysm, or bulge, in the aortic arch above his heart repaired in a novel and minimally invasive way.

Released:
22-May-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
thumbnail.png

Article ID: 694952

The Vessel Not Taken: Understanding Disproportionate Blood Flow

American Institute of Physics (AIP)

Considering the size of red blood cells, a new model for blood flow sheds light on why blood sometimes prefers some vessels over others.

Released:
22-May-2018 3:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 694813

Vasculitis Foundation Releases New Video, “What I Wish People Knew About Vasculitis” for Vasculitis Awareness Month 2018

Vasculitis Foundation

The VF has produced a new video as part of its Vasculitis Awareness Month campaign, that features patients sharing the one thing they wished people knew about their disease.

Released:
18-May-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Mitchelletal_horizontal.jpg
  • Embargo expired:
    17-May-2018 9:00 AM EDT

Article ID: 694507

Single Surface Protein Boosts Multiple Oncogenic Pathways in Acute Myeloid Leukemia, Study Reveals

The Rockefeller University Press

Researchers from the Albert Einstein College of Medicine in New York have discovered that a signaling protein elevated in patients with acute myeloid leukemia (AML) plays a much wider role in the disease than previously thought. The study, which will be published May 17 in the Journal of Experimental Medicine, raises hopes that current efforts to target this signaling protein could be a successful strategy to treat AML and other blood cancers.

Released:
14-May-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    16-May-2018 1:00 PM EDT

Article ID: 694528

Under Certain Conditions, Bacterial Signals Set the Stage for Leukemia

University of Chicago Medical Center

A new study by researchers from the University of Chicago Medicine shows that bacterial signals are crucial to the development of a precursor condition to leukemia, which can be induced by disrupting the intestinal barrier or by introducing a bacterial infection.

Released:
14-May-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 694521

Seattle Cancer Care Alliance Opens One of the Nation’s First Programs for Patients with Inherited Blood Cancer

Seattle Cancer Care Alliance

Seattle Cancer Care Alliance (SCCA) recently opened the Hematologic Malignancy Genetics Clinic, which provides personalized risk assessment and follow-up care for adult patients and family members who may be at increased risk for developing hematologic malignancies due to an underlying genetic cause.

Released:
16-May-2018 9:20 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 814





Chat now!